Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations
- PMID: 32199800
- DOI: 10.1016/j.jvsv.2020.01.008
Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations
Abstract
Objective: The aim of this study was to evaluate the safety and clinical outcomes of percutaneous sclerotherapy of venous disorders of the labia majora in patients with vascular malformations of the lower limbs.
Methods: Thirty percutaneous sclerotherapy treatments were performed over a 6-year period among 17 female patients with symptomatic venous malformation (VM) or secondary varicosis of the labia majora. Four patients were treated with sclerotherapy alone, 13 patients had additional procedures to control the VM before sclerotherapy. Polidocanol was used as sclerosant. Indications for sclerotherapy included pain, bleeding, thrombophlebitis, and swelling. Genitourinary symptoms were recorded. The number of treatments and procedure-related complications were registered. Complications were classified according to the Society of Interventional Radiology (SIR) classification system (grade A-E). The 3-month postintervention follow-up included magnetic resonance imaging, clinical examination, and a symptom-related questionnaire. If no reintervention was necessary, consultation was scheduled biannually.
Results: All patients had local swelling and pain; only a fraction of the patients had further symptoms with bleeding or thrombophlebitis (47% each). Eight patients required reintervention. No major complications were observed; minor complications such as postprocedural swelling occurred in 29% (SIR grade A), pain occurred in 17% (SIR grade B), and skin blistering developed in 5% (SIR grade B). Upon follow-up examination after a median of 40 months, 76% showed complete relief of symptoms, and 23% reported partial relief. All patients reported a substantial reduction in pain (75% >5 points in visual analogue scale) and swelling (88% complete cessation).
Conclusions: Percutaneous sclerotherapy is a safe and effective treatment option of VM and secondary varicosis of the labia majora.
Keywords: Adult; Angiography; Child; Female; Magnetic resonance imaging; Pain; Sclerosing solutions; Sclerotherapy; Vulva.
Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1066-1073. doi: 10.1016/j.jvsv.2019.11.022. Epub 2020 Apr 10. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32284311
-
Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1074-1082. doi: 10.1016/j.jvsv.2019.11.023. Epub 2020 Apr 10. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32284312
-
Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):209-219.e2. doi: 10.1016/j.jvsv.2020.03.011. Epub 2020 Jul 9. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 32653406
-
Percutaneous Sclerotherapy of Venous Malformations.Tech Vasc Interv Radiol. 2024 Jun;27(2):100960. doi: 10.1016/j.tvir.2024.100960. Epub 2024 Jun 14. Tech Vasc Interv Radiol. 2024. PMID: 39168545 Review.
-
Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.Eur J Vasc Endovasc Surg. 2011 Mar;41(3):412-7. doi: 10.1016/j.ejvs.2010.10.009. Epub 2010 Dec 15. Eur J Vasc Endovasc Surg. 2011. PMID: 21111641 Review.
Cited by
-
Results of interventional treatment of peripheral slow-flow malformations.CVIR Endovasc. 2023 Feb 10;6(1):5. doi: 10.1186/s42155-023-00352-3. CVIR Endovasc. 2023. PMID: 36763217 Free PMC article.
-
Microwave ablation with hydrodissection used for the treatment of vascular malformations: effectiveness and safety study.Front Oncol. 2024 Jun 4;14:1146972. doi: 10.3389/fonc.2024.1146972. eCollection 2024. Front Oncol. 2024. PMID: 38894863 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical